Patents Regulations (Amendment)

Legislation au C2004L05754 Regulations Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

STATUTORY RULES 1989 NO. 390

Issued by the Authority of the Minister of State for Industry, Technology and Commerce

The Statutory Rules amend the Patents Regulations to make implementing regulations for the Patents Amendment Act 1989 which replaces the present procedures for extending the term of a standard patent with new provisions enabling one-off 4 year extensions of term for certain standard patents for pharmaceutical substances for human use. Details of the amendments are as follows:

Regulation 1 cites the “Principal Regulations” as the Patents Regulations.

Regulation 2 amends subregulation 29(1) by adding a reference to new item 15A of Schedule 2, which sets out annual renewal fees for a patent whose term has been extended under section 95 of the Act (see regulation 7, below).

Regulation 3 repeals existing regulations 37, 38 and 39 and substitutes new regulations 37 to 39 and 39A to 39D.

New regulation 37 requires that an application for an extension of the term of a patent relating to a pharmaceutical substance must be in accordance with new Form 22A and be accompanied by the prescribed fee.

New regulation 38 prescribes for the purposes of section 91 of the Act the period within which the marketing approval certificate and a proposed claim or claims shall be given to the Commissioner, and requires the lapsing of an application under section 91 to be advertised in the Official Journal.

New regulation 39 provides that a marketing approval certificate must be in accordance with new Form 23.

New regulation 39A prescribes for the purposes of paragraph 93(2)(c) of the Act certain documents given to the Commissioner in relation to an application for extension. Under section 93, these prescribed documents are open to public inspection.

New regulation 39B prescribes the period within which a person may oppose an application for extension of the term of a patent relating to a pharmaceutical substance.

New regulation 39C requires particulars of a granted extension of term to be entered in the Register of Patents.


New subregulation 39D(1) requires a person who files an appeal under section 96B of the Act to request, within 7 days, the Commissioner to advertise the appeal in the Official Journal. New subregulation 39D(2) requires the appellant to request, within 7 days, the Commissioner to advertise in the Official Journal a final order or judgement of the Federal Court in relation to an appeal. New subregulation 39D(3) requires the Commissioner to publish an advertisement, in accordance with a request under subregulation (1) or (2), that states the particulars of the appeal or order. New subregulation 39D(4) defines the terms ‘appeal’ and ‘Federal Court’ within the meaning of new regulation 39D.

Regulation 4 makes a consequential amendment to the heading to Division 1 of Part XIV.

Regulation 5 repeals existing Division 2 of Part XIV and substitutes a new Division 2: “Proceedings in Cases of Opposition to Extension of the Term of a Standard Patent”.

New regulation 65 provides definitions of certain terms for the purposes of new Division 2.

New subregulation 66(1) specifies requirements for notices of opposition to an application for extension of term. New subregulation 66(2) provides for the Commissioner to allow the opponent to amend a notice of opposition if the amendment is necessary, and no other person will be unduly prejudiced. New subregulation 66(3) requires that the Commissioner, before allowing the amendment, must be satisfied that the applicant has been notified of the amendment, and give the parties involved opportunity to make representations about the proposed amendment. New subregulation 66(4) requires the opponent, within 14 days of giving the notice to the Commissioner, to serve on the applicant a copy of the notice or amended notice and each declaration not previously served on the applicant. New subregulation 66(5) provides for the withdrawal of an opposition to an application for an extension of term.

New regulation 67 requires notice of an opposition to be published in the Official Journal.

New regulation 68 requires that an applicant who has received a notice under subregulation 66(4) must within 3 months serve on the opponent a copy of any declarations on which the applicant intends to rely, and within 14 days of that service give the Commissioner each of those declarations and a notice specifying when and were the copies were served.

New subregulation 69(1) allows the Commissioner, on application or on his own motion, to give directions for the conduct of proceedings to which this Division applies. New subregulation 69(2) allows the Commissioner, on the application of a party to opposition proceedings, to permit the party to serve and lodge further declarations. New subregulation 69(3) requires that the


Commissioner, before giving a direction or allowing an application under the previous subsections, must be satisfied that the other party has been notified of the application or proposed action, and must give the parties an opportunity to make representations about the application or proposed action.

New regulation 70 provides that the Commissioner may extend the time, upon request, for a party to take any step under this Division, provided that the other party has been notified of the application, and that the parties have been given an opportunity to make representations concerning the proposed extension of time.

New regulation 71 sets out procedures for holding a hearing.

New regulation 71A allows the Commissioner to receive representations under specified provisions (which relate to amendment of notices, giving directions, lodgement of further declarations, and extensions of time) from the parties by correspondence or telephone and, if satisfied that each party is aware of all the representations, to act under those provisions without holding a hearing.

New regulation 71B allows the Commissioner, when making a determination on an application for an extension of term, to inform himself or herself of a fact by reference to documents in his or her custody, provided that the parties concerned have copies of, or, access to the documents; that they are aware that the Commissioner intends to refer to the document; and that they have had an opportunity to provide evidence or make representations regarding the fact or document.

New regulation 71C requires the Commissioner to send a copy of a determination under section 95 to each party.

New regulation 71D provides for the taxing, allowance, certification and review of costs.

Regulation 6 amends and omits certain forms and inserts new Forms 22A, 23 and 29A relating to extensions of term into the First Schedule to the Principal Regulations.

Regulation 7 amends Schedule 2 to the Principal Regulations by inseting new fee items 12A, 12B and 15A and amending fee items 9 and 19.

Regulation 8 provides that amendments made by these Regulations do not apply in relation to any proceedings that were pending under Part IX of the Act on 3 June 1988.

Overview

The Statutory Rules 1989 No. 390, issued under the authority of the Minister of State for Industry, Technology and Commerce, amends the Patents Regulations to implement the Patents Amendment Act 1989. This Act addresses a gap in the existing patent term extension procedures by replacing them with new provisions that enable one-off four-year extensions of term for certain standard patents related to pharmaceutical substances for human use. The primary objective of these amendments is to streamline and update the regulatory framework governing patent term extensions in response to advancements in pharmaceutical technologies and market needs. The enacting body responsible for these amendments is the Parliament, which authorised the changes to better align patent regulations with contemporary healthcare demands and foster innovation in the pharmaceutical sector. These regulations introduce new forms, fees, and procedural requirements for applications seeking patent term extensions, ensuring that the process is transparent, efficient, and accessible. They also incorporate provisions for public inspection of certain documents related to the extension applications and outline the procedures for handling oppositions to such applications. The amendments further detail the process for advertising appeals and final orders or judgments related to patent term extension applications in the Official Journal, ensuring that all stakeholders are adequately informed. Collectively, these changes aim to provide a robust framework that balances the interests of patent holders with those of the public, encouraging innovation while maintaining fair competition and public access to essential medicines.

Scope and Application

The Patents Amendment Act 1989, as implemented by the Statutory Rules 1989 No. 390, amends the Patents Regulations to introduce new procedures for extending the term of a standard patent specifically for pharmaceutical substances intended for human use. These regulations apply to entities seeking to extend the term of their patents, including pharmaceutical companies and patent holders within the Commonwealth of Australia. The new provisions enable a one-off extension of up to four years for eligible patents, thereby addressing the period between the patent grant and the substance's marketing approval by regulatory authorities. The application process requires compliance with newly prescribed forms and fees, and the Commissioner of Patents has the authority to manage oppositions and hearings related to these extensions. The regulations also outline procedures for advertising applications, oppositions, and decisions, ensuring transparency and public access to relevant information. Certain exclusions apply, particularly to proceedings pending before the specified effective date of 3 June 1988. Subordinate instruments may further detail or refine these regulations as needed.

Key Provisions

The Statutory Rules 1989 No. 390, issued under the authority of the Minister of State for Industry, Technology and Commerce, amend the Patents Regulations to implement new provisions enabling one-off four-year extensions of term for certain standard patents for pharmaceutical substances for human use, as per the Patents Amendment Act 1989. Regulation 2 adds a reference to new item 15A of Schedule 2, which concerns annual renewal fees for patents whose terms have been extended under section 95 of the Act (as per regulation 7). Regulation 3 replaces existing regulations 37, 38, and 39 with new regulations 37 to 39 and 39A to 39D. Regulation 37 mandates that applications for extensions must follow new Form 22A and include the required fee. Regulation 38 sets the timeframe for submitting a marketing approval certificate and proposed claims to the Commissioner and requires the lapse of an application under section 91 to be advertised in the Official Journal. Regulation 39 specifies that a marketing approval certificate must adhere to new Form 23. Regulation 39A details the documents to be submitted to the Commissioner for an extension application, which are available for public inspection under section 93. Regulation 39B stipulates the period within which an application for extension can be opposed. Regulation 39C mandates that particulars of a granted extension must be recorded in the Register of Patents. Regulation 39D outlines the process for advertising appeals and final orders or judgments of the Federal Court in the Official Journal. Regulation 5 introduces new Division 2, "Proceedings in Cases of Opposition to Extension of the Term of a Standard Patent," with definitions provided in regulation 65. Regulations 66 to 71D detail the procedures for opposition notices, amendments, publication, service of declarations, directions, time extensions, hearings, representations, determinations, and costs. Regulation 6 updates forms in the First Schedule to the Principal Regulations, while regulation 7 amends Schedule 2 to include new fee items 12A, 12B, and 15A, and adjusts fee items 9 and 19. Finally, regulation 8 specifies that these amendments do not apply to proceedings pending under Part IX of the Act on 3 June 1988. The obligations imposed by these regulations include filing applications for patent term extensions in accordance with new Form 22A and paying the prescribed fee, providing marketing approval certificates and proposed claims within specified timeframes, and adhering to the stipulated forms for certificates and other required documents. The Commissioner must advertise lapses of applications under section 91 and ensure that particulars of granted extensions are recorded in the Register of Patents. Parties involved in opposition proceedings must serve notices, declarations, and other documents as required, and the Commissioner has the authority to give directions, allow amendments, extend time limits, and hold or forgo hearings as appropriate. Additionally, the Commissioner must send copies of determinations to all parties and handle the taxing, allowance, certification, and review of costs. Violations of these regulations may lead to civil or criminal consequences, though specific penalties are not detailed in the explanatory statement. Given the nature of the amendments, breaches might result in fines, imprisonment, or other penalties as prescribed by relevant laws. The maximum penalties would depend on the specific offence and the discretion of the court.

Legal classification tags

Area of Law
Intellectual Property Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Regulatory Standards
Reporting & Disclosure Obligations
Compliance Obligations
Enforcement Powers

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.